LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
Zhang Hongkai,
Zhang Jianni,
Dong Lining,
Ma Rong
Affiliations
Zhang Hongkai
Department of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, China
Zhang Jianni
Department of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, China
Dong Lining
Department of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, China
Ma Rong
Department of Cell Medicine, International Healthy Cells Rehabilitation Association, Shanghai Liangliang Biotechnology Co., Ltd, No. 876 Taogan Road, Sheshan District 201602, Shanghai, China
Tamoxifen (TAMR) resistance remains a massive obstacle for breast cancer (BC) management. The precise parts of long non-coding RNA ataxin 8 opposite strand (ATXN8OS) in BC TAMR resistance have not been defined.
